ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Postoperative circulating cell-free DNA (cfDNA) dynamics as an early indicator of molecular residual disease in lung cancer: preliminary results and correlation with TNM status, adjuvant therapy, and clinical outcome
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Liquid Biopsy in Lung Cancer#1114342
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer#873612
- Circulating Tumor DNA in Patients at High Risk for Lung Cancer#1074487
- Cancer Panel From Blood of Lung Cancer Patients#900850
- Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study#832759
Record · ID 245139
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive